Abstract
We describe a 57-year-old man, affected by large granular lymphocyte (LGL) leukemia and concomitant primary progressive multiple sclerosis (MS), treated with allogeneic hematopoietic stem cell transplantation (HSCT) from an HLA-identical sibling. The patient was conditioned with fludarabine, busulphan, and cyclophosphamide. Graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporine and short-term methotrexate. At 3 years follow-up, the patient is in complete remission of LGL with a marked improvement in neurological conditions. This is the first case of allogeneic HSCT in a patient with LGL leukemia and concomitant primary progressive MS. Allogeneic HSCT, performed in our patient to cure the lymphoproliferative disorder, improved the clinical course of MS.
Similar content being viewed by others
References
Greer JP, Kinney MC, Loughran TP Jr (2001) T cell and NK cell lymphoproliferative disorders. Hematology (Am Soc Hematol Educ Program) 259–281
Noseworthy JH, Lucchinetti C, Rodriguez M, et al. (2000) Multiple Sclerosis. N Engl J Med 343:938–952
Compston DA, Coles A (2002) Multiple sclerosis. Lancet 359:1221–1231
Mancardi GL, Saccardi R, Filippi M, et al. (2001) Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. Neurology 57:62–68
Fassas A, Passweg JR, Anagnostopoulos A, et al. (2002) Autoimmune Disease Working Party of the EBMT (European Group for Blood and Marrow Transplantation). Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 249:1088–1097
McAllister LD, Beatty PG, Rose J (1997) Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis. Bone Marrow Transplant 19: 395–397
Mandalfino P, Rice G, Smith A, et al. (2000) Bone marrow transplantation in multiple sclerosis. J Neurol 247:691–695
Hinterberger W, Hinterberger-Fischer M, Marmont A (2002) Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 30:753–759
Marmont AM, Gualandi F, Van Lint MT, Bacigalupo A (2003) Refractory Evans’ syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 3:399–402
Burt RK, Traynor AE, Craig R, Marmont AM (2003) The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 3:521–524
Marmont AM (2001) Immunoablation followed or not by hematopoietic stem cells as an intense therapy for severe autoimmune diseases. New perspectives, new problems. Haematologica 86:337–345
Thompson AJ, Montalban X, Barkhof F, et al. (2000) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831–835
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Filippi M, Rovaris M, Capra R, et al. (1998) A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 121:2011–2020
Perron H, Garson JA, Bedin F, et al. (1997) Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A 94:7583–7588
Loughran TP Jr, Hadlock KG, Perzova R, et al. (1998) Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 101:318–324
Acknowledgements
We are grateful to Prof. Alberto Marmont for his precious comments and critical revision of the manuscript. We also wish to thank Mrs. Anna Koopmans for her assistance in preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
La Nasa, G., Littera, R., Cocco, E. et al. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. Ann Hematol 83, 403–405 (2004). https://doi.org/10.1007/s00277-003-0801-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-003-0801-3